Arcutis Biotherapeutics, Inc. (ARQT)
21.46
+0.02
(+0.09%)
USD |
NASDAQ |
May 29, 16:00
21.44
-0.02
(-0.09%)
After-Hours: 20:00
Arcutis Biotherapeutics EPS Diluted (Quarterly) : -0.0873 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Incyte Corp. | 1.467 |
| MannKind Corp. | -0.0539 |
| PTC Therapeutics, Inc. | -0.034 |
| Capricor Therapeutics, Inc. | -0.591 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.30M |
| Revenue (Quarterly) | 105.40M |
| Total Expenses (Quarterly) | 116.69M |
| Enterprise Value | 2.575B |
| Gross Profit Margin (Quarterly) | 90.72% |
| Profit Margin (Quarterly) | -10.72% |
| Earnings Yield | -0.13% |
| Operating Earnings Yield | 0.11% |
| Normalized Earnings Yield | -0.1305 |